Qube Research & Technologies LTD Arbutus Biopharma Corp Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.69 - $2.54 $11,030 - $16,578	-6,527 Reduced 79.48%	1,685 $4,000
Q3 2023 Nov 13, 2023	SELL	$1.9 - $2.27 $17,035 - $20,352	-8,966 Reduced 52.19%	8,212 $16,000
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $10,855 - $14,828	-4,846 Reduced 22.0%	17,178 $39,000
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $49,113 - $68,274	22,024 New	22,024 $66,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $41,006 - $71,489	-15,474 Closed	0 $0

Q2 2021 Aug 13, 2021	SELL	$2.5 - $3.51 $262,637 - $368,743	-105,055 Reduced 87.16%	15,474 $47,000
Q1 2021 May 14, 2021	SELL	$3.14 - $4.84 $828,231 - $1.28 Million	-263,768 Reduced 68.64%	120,529 $401,000
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $947,295 - $1.71 Million	343,223 Added 835.62%	384,297 $1.36 Million
Q3 2020 Nov 12, 2020	SELL	$1.75 - $6.2 $31,218 - $110,601	-17,839 Reduced 30.28%	41,074 $129,000
Q2 2020 Aug 14, 2020	BUY	$0.91 - $2.36 $13,644 - $35,385	14,994 Added 34.14%	58,913 $107,000
Q1 2020 May 15, 2020	SELL	$1.01 - $3.42 $123,441 - $417,988	-122,219 Reduced 73.56%	43,919 $44,000
Q4 2019 Feb 13, 2020	BUY	$0.87 - $2.89 $144,540 - $480,138	166,138 New	166,138 $462,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.